Syndromic Surveillance of Gastroenteritis Using Medication Sales in France - PowerPoint PPT Presentation

1 / 16
About This Presentation
Title:

Syndromic Surveillance of Gastroenteritis Using Medication Sales in France

Description:

Gastroenteritis epidemics. etiology unclear but medication sales detect outbreaks of bacterial and viral origin [4, 5] ... detecting gastroenteritis epidemics ... – PowerPoint PPT presentation

Number of Views:71
Avg rating:3.0/5.0
Slides: 17
Provided by: syndr
Category:

less

Transcript and Presenter's Notes

Title: Syndromic Surveillance of Gastroenteritis Using Medication Sales in France


1
Syndromic Surveillance of Gastroenteritis Using
Medication Sales in France
  • Camille Pelat 1,2, Clément Turbelin 1,2,
    Pierre-Yves Boëlle 1,2, Bruno Lambert 3 and
    Alain-Jacques Valleron 1,2
  • (1) INSERM UMR-S 707, (2) Université Pierre et
    Marie Curie, (3) IMS-Health France

2
Use of drug sales data for surveillance
  • Medication sales are a good proxy of the
    incidence of acute illnesses
  • influenza-like or gastrointestinal illness
    outbreaks 1
  • thresholds for surveillance of bioterrorist
    attacks 2
  • forecast ILI incidences 3
  • Gastroenteritis epidemics
  • etiology unclear but medication sales detect
    outbreaks of bacterial and viral origin 4, 5
  • Aim of this work create an indicator based on
    pharmaceutical data to detect gastroenteritis
    epidemics
  • Validate it at the national level using clinical
    surveillance data

3
Data
  • Clinical data
  • Sentinel Network data available on
    www.sentiweb.fr
  • Since 1990 100 General Practitioners report
    Acute Diarrhea cases (WHO definition) each week
  • Drug sales
  • IMS-Health
  • 13,000 pharmacies (gt50 of all) 10,000 by week
    send data
  • Therapeutic classes EPhMRA ATC
  • (European Pharmaceutical Market Research
    Association
  • Anatomical Therapeutic Chemical Classification
    System)
  • 582 therapeutic classes
  • Unit number of boxes sold each week by
    therapeutic class
  • Since 2000

4
Methods (1/3)
  • Data mining approach to identify therapeutic
    classes linked to Acute Diarrhea (AD)
  • Hierarchical tree on the time series of the
    therapeutic classes incidence of AD
  • Takes into account the distance of therapeutic
    classes between themselves with incidence of AD
  • Creates clusters of homogeneous time series
  • Distance between 2 series 1-correlation at the
    best lag
  • Identify the cluster that contains incidence of
    AD
  • Therapeutic classes of this cluster are
    candidates for the detection of gastroenteritis
    epidemics

5
Methods (2/3)
  • Detect epidemics in the time series of the
    selected therapeutic classes
  • Principle historical data used to set detection
    threshold
  • Changes in the mean and the variance of series ?
    method that relies on few historical data
  • Limited Baseline CUSUM
  • Sum of the differences between observed and
    expected values
  • One-sided CUSUM only positive deviations are
    searched
  • Alert when the sum exceeds a predefined threshold
  • Create a unique indicator of epidemics
  • Global alert if at least n of the selected
    classes emit an alert

6
Methods (3/3)
  • Evaluation
  • Gold standard alerts published by the Sentinel
    Network, relying on the incidence of acute
    diarrhea
  • Epidemic weeks weeks defined as epidemic by the
    gold standard the 2 preceding weeks
  • An epidemic was detected if an alert was emitted
    for at least one of the epidemic weeks
  • Metric 6
  • Sensitivity detected epidemics / epidemics
  • Specificity of non-epidemic weeks without
    alert / of non-epidemic weeks
  • Timeliness detection time time of the gold
    standard alert

7
Selection of the therapeutic classes (1/2)
Clus 1
Clus 2
  • Hierarchical tree
  • therapeutic classes
  • AD incidence

Clus 3
Clus 4
etc
To provide distincts clusters
Tree is cut at the distance 0.55
Distance between series
Names of series
8
Selection of the therapeutic classes (2/2)

plt0.001
  • 8 classes in the same cluster than AD incidence
  • All medically linked to gastroenteritis
  • Best correlation when lag is 0 except for the
    gastroprokinetics they are 1 week late over AD
    incidence
  • Best correlation for motility inhibitors 0.78

9
Time series of the selected classes (1/2)
Therapeutic Class
Rescaled Acute Diarrhea Incidence
10
Time series of the selected classes (2/2)
Therapeutic Class
Rescaled Acute Diarrhea Incidence
11
CUSUM on the selected classes


At a fixed specificity of 0.95
  • At a fixed specificity of 0.95, intestinal
    anti-infective antidiarrheals have the best
    performances
  • Sensitivity is 1
  • Timeliness is in average 1 week before the gold
    standard

12
Alerts of the global indicator



At a fixed specificity of 0.95
  • At a fixed specificity of 0.95, the detection
    rule that optimizes the sensitivity and the
    timeliness is
  •  emit a global alert if at least 5 classes emit
    an alert 
  • Sensitivity is 1
  • Timeliness is 1 week before the gold standard

13
Discussion
  • 8 medically pertinent classes selected by data
    mining
  • Many papers expert advice
  • Antidiarrheals and antiemetics used by other
    papers
  • Plain antispasmodics and anticholinergics,
    gastroprokinetics new
  • Simultaneous monitoring vs single monitoring ?
  • Global indicator same performance than best
    therapeutic class (A07A, intestinal
    anti-infective antidiarrheals )
  • Monitor a global indicator composed of 8 classes
    more robustness against future unexpected changes
    in one series
  • Due to other cause than an epidemic (commercial,
    legal, etc)

14
Conclusion
  • Efficient data source for detecting
    gastroenteritis epidemics
  • Good sensitivity, specificity, timeliness
  • Massive sample of pharmacies
  • Indicator validated at the national level
  • Operational application additional data source
    for Sentinel Network
  • More confidence when emitting alert
  • Perspective regional level
  • Use indicator to detect outbreaks where few
    Sentinel GP

15
  • Thank you

16
References
  • 1 Das, et al. (2005). MMWR Morb Mortal Wkly Rep
    54 Suppl 41-6.
  • 2 Goldenberg, et al. (2002). Proc Natl Acad Sci
    U S A 99(8) 5237-40.
  • 3 Vergu, et al. (2006). Emerg Infect Dis 12(3)
    416-21.
  • 4 Edge, et al. (2004). Can J Public Health
    95(6) 446-50.
  • 5 Edge, et al. (2006). Can J Infect Dis Med
    Microbiol 17(4) 235-41.
  • 6 Kleinman, K. P. and A. M. Abrams (2006). Stat
    Methods Med Res 15(5) 445-64.
Write a Comment
User Comments (0)
About PowerShow.com